Type 1 Diabetes Clinical Trials in Boston, Massachusetts

6 studies are recruiting for type 1 diabetes in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

   This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evalua…

   Stage

   Phase 1

   Ages

   12 to 35

   Site

   Joslin Diabetes Center, Boston, Massachusetts

   Locations

   45 in total

   Run by

   COUR Pharmaceutical Development Company, Inc.

   See if you can join NCT06783309 on ClinicalTrials.gov

2. SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

   This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).

   Stage

   Phase 2

   Ages

   5 to 40

   Site

   Harvard Medical School - Joslin Diabetes Center and Joslin Clinical (JDS), Boston, Massachusetts

   Locations

   70 in total

   Run by

   SAb Biotherapeutics, Inc.

   See if you can join NCT07187531 on ClinicalTrials.gov

3. Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

   This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Harvard Medical School, Boston, Massachusetts

   Locations

   7 in total

   Run by

   Indiana University

   See if you can join NCT07676565 on ClinicalTrials.gov

4. Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

   This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.

   Stage

   Not phased

   Ages

   18 to 64

   Site

   Boston University, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Albert Einstein College of Medicine

   See if you can join NCT05734313 on ClinicalTrials.gov

5. PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

   This research study is called 'PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life: The PROMISE Study'. The purpose of this study is to find out more about how exposures during pregnancy, such as having an infection, diet and growth may impact later risk of type 1 diabe…

   Stage

   Not phased

   Ages

   0 to 99

   Site

   Joslin Diabetes Center, Boston, Massachusetts

   Locations

   4 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT06141434 on ClinicalTrials.gov

6. The T1D Exchange Registry

   The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity…

   Stage

   Not phased

   Ages

   Any age

   Site

   T1D Exchange, Boston, Massachusetts

   Run by

   T1D Exchange, United States

   See if you can join NCT04629586 on ClinicalTrials.gov